Analisi dei costi di quattro strategie terapeutiche nella gestione di pazienti con broncopneumopatia (BPCO) moderata o severa: un’applicazione del metodo bootstrap

Lucioni C, Donner C, De Benedetto F, et al. I costi della broncopneumatopia cronica ostruttiva in Italia. Presentazione della prima fase dello studio ICE (Italian Costs for Exacerbations in COPD). Pharmacoeconomics-Italian Research Articles 2004; 6: 5–14

Pauwels R, Rabe K. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613–20

Wouters EFM. Economic analysis of the Confronting COPD survey: an overview of results. Respir Med 2003; 97 (Suppl. C): S3–14

Dal Negro R, Rossi A, Cerveri I. The burden of COPD in Italy: results from the Confronting COPD survey. Respir Med 2003; 97 (Suppl. C): S43–50

Motterlini N, Koleva D, Garattini L. I costi della BPCO in Italia: l’analisi retrospettiva dello studio BIC. Economia e Politica del Farmaco 2005; 4: 20–8

Ministero della Salute. Statistiche sui ricoveri ospedalieri www.ministerosalute.it , visitato il 30/06/2004

Szafranski W, Cukier A, Ramirez A, et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Resp J 2003; 21: 74–81

Calverley PM, Boonsawat W, Cseke Z, et al. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 2003; 22: 912–9

Koopmanschap M, Touw K, Rutten F. Analysis of costs and cost-effectiveness in multinational trials. Health Policy 2001; 58: 175–86

Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000; 19: 3219–36

O’Hagan A, Stevens JW. Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? Health Econ 2003; 12: 33–49

Desgagne A, Castilloux AM, Angers JF, LeLorier J. The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics 1998; 13: 487–97